Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4042 USD | +0.90% | +2.33% | -12.15% |
Mar. 20 | UBS Adjusts Singular Genomics Systems Price Target to $0.50 From $0.40, Maintains Neutral Rating | MT |
Mar. 18 | Transcript : Singular Genomics Systems, Inc., Q4 2023 Earnings Call, Mar 18, 2024 |
Financials (USD)
Sales 2024 * | 2.42M | Sales 2025 * | 14.18M | Capitalization | 29.95M |
---|---|---|---|---|---|
Net income 2024 * | -87M | Net income 2025 * | -82M | EV / Sales 2024 * | 12.1 x |
Net cash position 2024 * | 788K | Net Debt 2025 * | 25.13M | EV / Sales 2025 * | 3.88 x |
P/E ratio 2024 * |
-0.35
x | P/E ratio 2025 * |
-0.38
x | Employees | 255 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.58% |
Latest transcript on Singular Genomics Systems, Inc.
1 day | +0.90% | ||
1 week | +2.33% | ||
Current month | -21.39% | ||
1 month | -21.79% | ||
3 months | -14.00% | ||
6 months | +21.38% | ||
Current year | -12.15% |
Managers | Title | Age | Since |
---|---|---|---|
Eli Glezer
FOU | Founder | 55 | 16-05-31 |
Andrew Spaventa
CEO | Chief Executive Officer | 39 | 16-05-31 |
Dalen Meeter
DFI | Director of Finance/CFO | 46 | 19-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Barker
FOU | Founder | 82 | 16-08-31 |
Kim Kamdar
BRD | Director/Board Member | 56 | 17-04-30 |
Michael Pellini
BRD | Director/Board Member | 58 | 17-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 9 M€ | +6.26% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.4042 | +0.90% | 106,287 |
24-04-25 | 0.4006 | -1.67% | 18,125 |
24-04-24 | 0.4074 | -1.69% | 34,110 |
24-04-23 | 0.4144 | +3.60% | 77,813 |
24-04-22 | 0.4 | +1.27% | 43,805 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.15% | 29.95M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- OMIC Stock